Share Price and Basic Stock Data
Last Updated: January 19, 2026, 10:17 pm
| PEG Ratio | 44.75 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vakrangee Ltd, operating in the IT Consulting and Software industry, reported a market capitalization of ₹805 Cr and a share price of ₹7.44. The company has witnessed fluctuating sales, with revenues of ₹234.07 Cr in September 2022, declining to ₹49.15 Cr by December 2022, and then gradually improving to ₹55.59 Cr in June 2023. The most recent quarterly sales in September 2023 stood at ₹51.54 Cr. Annual sales have shown a modest recovery, with ₹197 Cr recorded for FY 2023 and a projected ₹213 Cr for FY 2024. However, the trailing twelve months (TTM) sales reached ₹269 Cr, indicating a slight upward trend. Such fluctuations may reflect the company’s challenges in maintaining consistent revenue streams, which could be a concern for stakeholders. The company’s operational performance is further illustrated by the operating profit margin (OPM), which reported a low of 4.12% in September 2022, peaking at 14.12% in March 2024 before settling at 10.52% in the latest period.
Profitability and Efficiency Metrics
Vakrangee’s profitability metrics reveal significant volatility, particularly in net profit figures. The company reported a net profit of ₹10 Cr for FY 2023, with a net profit margin of 2.50% for FY 2025. This is a notable improvement from the net profit of ₹1 Cr in FY 2022, indicating a recovery phase. The return on equity (ROE) stood at 3.65%, while the return on capital employed (ROCE) was recorded at 5.86%, both relatively low compared to industry averages, suggesting room for improvement. Additionally, the interest coverage ratio (ICR) was a robust 15.39x, indicating that the company comfortably covers its interest obligations. However, the fluctuating operating profit margins, which varied between 4.12% and 14.12% over recent quarters, signal potential inefficiencies in managing costs relative to sales. The company’s cash conversion cycle (CCC) improved to 45 days, reflecting better management of receivables and payables, although it still remains a focus area for operational efficiency enhancement.
Balance Sheet Strength and Financial Ratios
Vakrangee’s balance sheet reflects a cautious financial strategy, with total borrowings reported at ₹4 Cr and reserves of ₹100 Cr as of the latest filings. The absence of long-term debt indicates a conservative approach to leverage, which can be favorable in times of financial distress. The current ratio stood at 2.15x, signaling healthy liquidity, while the quick ratio at 1.90x further supports this liquidity position, suggesting that the company can meet its short-term obligations comfortably. However, the price-to-book value ratio (P/BV) at 5.75x indicates that the stock is trading at a premium compared to its book value of ₹1.64 per share. This high valuation ratio might raise concerns regarding overvaluation, especially in light of the company’s lackluster profitability metrics. Furthermore, the total assets were reported at ₹309 Cr, with a significant portion tied up in other assets, which may not yield immediate returns, thus warranting scrutiny from investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vakrangee showcases a dominant public ownership, which stood at 54.66%, while promoters hold 40.05% of the company. This distribution reflects a healthy level of public interest, although the decline in promoter shareholding from 42.60% in December 2022 to the current levels raises questions about their confidence in the company’s future. The foreign institutional investors (FIIs) and domestic institutional investors (DIIs) represent a modest presence, with FIIs at 0.83% and DIIs at 4.47%. The increase in the number of shareholders, from 2,16,531 in December 2022 to 4,16,518 in September 2025, indicates growing retail investor interest. However, the low institutional investment could suggest hesitance from larger investors, potentially due to the company’s erratic financial performance and profitability challenges. As investor sentiment plays a crucial role in stock performance, the company must work on building investor confidence through consistent financial results and strategic growth initiatives.
Outlook, Risks, and Final Insight
Looking ahead, Vakrangee faces several risks that could impact its financial stability and growth trajectory. The primary concerns include its inconsistent revenue streams, fluctuating profitability metrics, and high valuation ratios. Furthermore, the company’s dependence on public ownership may pose risks in terms of stock price volatility, especially in adverse market conditions. Strengths include a solid interest coverage ratio, a conservative borrowing strategy, and an improving cash conversion cycle, which could provide operational resilience. To enhance its market position, Vakrangee must focus on stabilizing its sales and improving profitability through better cost management and operational efficiencies. If the company can successfully navigate these challenges and leverage its strengths, it may position itself for long-term growth and increased investor confidence. Conversely, failure to address these issues could hinder its recovery and growth, leaving stakeholders wary of its future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 63.9 Cr. | 20.2 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 131 Cr. | 122 | 194/99.8 | 20.1 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 40.6 Cr. | 317 | 318/140 | 25.4 | 26.7 | 0.32 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.61 Cr. | 1.04 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,778.77 Cr | 551.33 | 82.73 | 123.77 | 0.58% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 234.07 | 49.15 | 50.94 | 55.59 | 51.54 | 51.56 | 53.89 | 58.70 | 65.25 | 67.88 | 63.18 | 68.84 | 69.08 |
| Expenses | 224.43 | 44.15 | 46.22 | 48.97 | 45.62 | 45.33 | 46.28 | 52.14 | 60.01 | 62.40 | 56.35 | 61.02 | 61.81 |
| Operating Profit | 9.64 | 5.00 | 4.72 | 6.62 | 5.92 | 6.23 | 7.61 | 6.56 | 5.24 | 5.48 | 6.83 | 7.82 | 7.27 |
| OPM % | 4.12% | 10.17% | 9.27% | 11.91% | 11.49% | 12.08% | 14.12% | 11.18% | 8.03% | 8.07% | 10.81% | 11.36% | 10.52% |
| Other Income | 1.36 | -0.05 | 0.86 | 0.31 | 0.87 | 1.32 | 0.39 | 0.89 | 0.82 | 0.75 | 1.55 | 1.51 | 1.64 |
| Interest | 0.00 | 0.00 | 1.52 | 1.99 | 1.83 | 1.93 | 1.96 | 0.45 | 0.60 | 0.38 | 0.40 | 0.36 | 0.35 |
| Depreciation | 4.19 | 4.01 | 3.39 | 3.95 | 3.97 | 3.92 | 3.85 | 3.89 | 4.28 | 4.24 | 4.29 | 4.30 | 4.45 |
| Profit before tax | 6.81 | 0.94 | 0.67 | 0.99 | 0.99 | 1.70 | 2.19 | 3.11 | 1.18 | 1.61 | 3.69 | 4.67 | 4.11 |
| Tax % | 29.22% | 86.17% | -1.49% | 49.49% | 57.58% | 26.47% | 0.00% | 27.97% | 50.85% | 35.40% | 31.71% | 28.91% | 26.28% |
| Net Profit | 4.82 | 0.13 | 0.68 | 0.49 | 0.42 | 1.24 | 2.19 | 2.24 | 0.59 | 1.04 | 2.52 | 3.32 | 3.03 |
| EPS in Rs | 0.05 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
Last Updated: December 28, 2025, 3:31 pm
Below is a detailed analysis of the quarterly data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 69.08 Cr.. The value appears strong and on an upward trend. It has increased from 68.84 Cr. (Jun 2025) to 69.08 Cr., marking an increase of 0.24 Cr..
- For Expenses, as of Sep 2025, the value is 61.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.02 Cr. (Jun 2025) to 61.81 Cr., marking an increase of 0.79 Cr..
- For Operating Profit, as of Sep 2025, the value is 7.27 Cr.. The value appears to be declining and may need further review. It has decreased from 7.82 Cr. (Jun 2025) to 7.27 Cr., marking a decrease of 0.55 Cr..
- For OPM %, as of Sep 2025, the value is 10.52%. The value appears to be declining and may need further review. It has decreased from 11.36% (Jun 2025) to 10.52%, marking a decrease of 0.84%.
- For Other Income, as of Sep 2025, the value is 1.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.51 Cr. (Jun 2025) to 1.64 Cr., marking an increase of 0.13 Cr..
- For Interest, as of Sep 2025, the value is 0.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Jun 2025) to 0.35 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 4.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.30 Cr. (Jun 2025) to 4.45 Cr., marking an increase of 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.11 Cr.. The value appears to be declining and may need further review. It has decreased from 4.67 Cr. (Jun 2025) to 4.11 Cr., marking a decrease of 0.56 Cr..
- For Tax %, as of Sep 2025, the value is 26.28%. The value appears to be improving (decreasing) as expected. It has decreased from 28.91% (Jun 2025) to 26.28%, marking a decrease of 2.63%.
- For Net Profit, as of Sep 2025, the value is 3.03 Cr.. The value appears to be declining and may need further review. It has decreased from 3.32 Cr. (Jun 2025) to 3.03 Cr., marking a decrease of 0.29 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.03. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,952 | 2,780 | 3,191 | 4,000 | 6,502 | 1,508 | 685 | 314 | 194 | 197 | 213 | 255 | 269 |
| Expenses | 1,417 | 2,057 | 2,370 | 3,054 | 5,495 | 1,530 | 661 | 286 | 176 | 179 | 186 | 231 | 242 |
| Operating Profit | 535 | 723 | 821 | 946 | 1,007 | -22 | 24 | 28 | 18 | 19 | 26 | 24 | 27 |
| OPM % | 27% | 26% | 26% | 24% | 15% | -1% | 3% | 9% | 9% | 9% | 12% | 9% | 10% |
| Other Income | 6 | 6 | 6 | 5 | 34 | 82 | 83 | 70 | 2 | 1 | 3 | 4 | 5 |
| Interest | 78 | 75 | 56 | 50 | 10 | 0 | 0 | 0 | 0 | 2 | 8 | 2 | 1 |
| Depreciation | 181 | 165 | 164 | 73 | 7 | 9 | 15 | 15 | 15 | 16 | 16 | 17 | 17 |
| Profit before tax | 282 | 489 | 606 | 828 | 1,024 | 51 | 92 | 83 | 5 | 3 | 6 | 10 | 14 |
| Tax % | 38% | 34% | 35% | 36% | 34% | 51% | 22% | 24% | 100% | 63% | 26% | 33% | |
| Net Profit | 175 | 322 | 395 | 531 | 680 | 25 | 71 | 63 | 0 | 1 | 4 | 6 | 10 |
| EPS in Rs | 1.74 | 3.20 | 3.73 | 5.02 | 6.43 | 0.24 | 0.67 | 0.59 | 0.00 | 0.01 | 0.04 | 0.06 | 0.09 |
| Dividend Payout % | 7% | 4% | 17% | 20% | 4% | 105% | 37% | 17% | 530% | 122% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 84.00% | 22.67% | 34.43% | 28.06% | -96.32% | 184.00% | -11.27% | -100.00% | 300.00% | 50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -61.33% | 11.76% | -6.37% | -124.38% | 280.32% | -195.27% | -88.73% | 400.00% | -250.00% |
Vakrangee Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -18% |
| 3 Years: | 10% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -37% |
| 3 Years: | % |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -16% |
| 5 Years: | -19% |
| 3 Years: | -34% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 53 | 53 | 106 | 106 | 106 | 106 | 106 | 106 | 106 | 108 | 108 |
| Reserves | 729 | 1,157 | 1,530 | 2,001 | 2,487 | 2,496 | 2,531 | 2,558 | 22 | 18 | 56 | 94 | 100 |
| Borrowings | 492 | 416 | 320 | 144 | 0 | 0 | 0 | 0 | 27 | 58 | 12 | 5 | 4 |
| Other Liabilities | 453 | 414 | 189 | 71 | 400 | 116 | 182 | 212 | 178 | 116 | 126 | 102 | 130 |
| Total Liabilities | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
| Fixed Assets | 436 | 273 | 132 | 29 | 90 | 143 | 149 | 156 | 139 | 127 | 114 | 110 | 119 |
| CWIP | 48 | 10 | 0 | 0 | 3 | 13 | 5 | 5 | 6 | 8 | 10 | 17 | 9 |
| Investments | 3 | 2 | 2 | 2 | 29 | 4 | 3 | 1 | 2 | 3 | 7 | 4 | 5 |
| Other Assets | 1,238 | 1,753 | 1,959 | 2,238 | 2,871 | 2,558 | 2,662 | 2,714 | 186 | 160 | 169 | 177 | 210 |
| Total Assets | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
Below is a detailed analysis of the balance sheet data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 108.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 108.00 Cr..
- For Reserves, as of Sep 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 28.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 343.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Mar 2025) to 119.00 Cr., marking an increase of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 8.00 Cr..
- For Investments, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 177.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
Notably, the Reserves (100.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 43.00 | 307.00 | 501.00 | 802.00 | 1.00 | -22.00 | 24.00 | 28.00 | -9.00 | -39.00 | 14.00 | 19.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 144 | 157 | 97 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 39 |
| Inventory Days | 45 | 31 | 81 | 223 | ||||||||
| Days Payable | 71 | 39 | 18 | 217 | ||||||||
| Cash Conversion Cycle | 119 | 149 | 160 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 45 |
| Working Capital Days | 66 | 124 | 137 | 129 | 55 | 310 | 894 | 2,188 | -145 | -53 | -6 | 4 |
| ROCE % | 31% | 39% | 37% | 43% | 43% | 2% | 3% | 3% | 0% | 3% | 7% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Diluted EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Cash EPS (Rs.) | 0.21 | 0.18 | 0.15 | 1.18 | 0.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Revenue From Operations / Share (Rs.) | 2.35 | 2.01 | 1.86 | 7.35 | 2.97 |
| PBDIT / Share (Rs.) | 0.25 | 0.27 | 0.18 | 1.50 | 0.92 |
| PBIT / Share (Rs.) | 0.10 | 0.12 | 0.03 | 1.35 | 0.78 |
| PBT / Share (Rs.) | 0.08 | 0.05 | 0.02 | 1.34 | 0.78 |
| Net Profit / Share (Rs.) | 0.05 | 0.04 | 0.01 | 1.03 | 0.59 |
| NP After MI And SOA / Share (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| PBDIT Margin (%) | 11.02 | 13.51 | 9.98 | 20.37 | 31.06 |
| PBIT Margin (%) | 4.48 | 6.12 | 2.12 | 18.39 | 26.35 |
| PBT Margin (%) | 3.76 | 2.75 | 1.35 | 18.17 | 26.35 |
| Net Profit Margin (%) | 2.50 | 2.04 | 0.50 | 14.06 | 19.97 |
| NP After MI And SOA Margin (%) | 2.61 | 2.04 | 0.50 | 14.06 | 19.97 |
| Return on Networth / Equity (%) | 3.75 | 3.61 | 0.81 | 3.98 | 2.35 |
| Return on Capital Employeed (%) | 4.85 | 6.92 | 2.68 | 5.20 | 3.10 |
| Return On Assets (%) | 2.15 | 1.45 | 0.33 | 3.73 | 2.18 |
| Long Term Debt / Equity (X) | 0.00 | 0.06 | 0.10 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.10 | 0.46 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.83 | 0.71 | 0.10 | 0.24 | 0.08 |
| Current Ratio (X) | 2.15 | 1.40 | 1.05 | 11.93 | 10.20 |
| Quick Ratio (X) | 1.90 | 1.40 | 1.04 | 11.90 | 10.17 |
| Inventory Turnover Ratio (X) | 26.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 81.17 | 121.71 | 527.21 | 9.67 | 42.17 |
| Dividend Payout Ratio (CP) (%) | 23.13 | 26.43 | 32.07 | 8.47 | 34.13 |
| Earning Retention Ratio (%) | 18.83 | -21.71 | -427.21 | 90.33 | 57.83 |
| Cash Earning Retention Ratio (%) | 76.87 | 73.57 | 67.93 | 91.53 | 65.87 |
| Interest Coverage Ratio (X) | 15.39 | 3.72 | 13.01 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 4.50 | 1.49 | 1.66 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 947.72 | 2066.51 | 1718.30 | 3625.04 | 5916.69 |
| EV / Net Operating Revenue (X) | 3.72 | 9.72 | 8.71 | 4.66 | 18.83 |
| EV / EBITDA (X) | 33.70 | 71.95 | 87.18 | 22.84 | 60.61 |
| MarketCap / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| Retention Ratios (%) | 18.82 | -21.71 | -427.21 | 90.32 | 57.82 |
| Price / BV (X) | 5.75 | 17.47 | 13.70 | 1.34 | 2.23 |
| Price / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
After reviewing the key financial ratios for Vakrangee Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 3. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.35. It has increased from 2.01 (Mar 24) to 2.35, marking an increase of 0.34.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 2. It has decreased from 0.27 (Mar 24) to 0.25, marking a decrease of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is within the healthy range. It has decreased from 0.12 (Mar 24) to 0.10, marking a decrease of 0.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For PBDIT Margin (%), as of Mar 25, the value is 11.02. This value is within the healthy range. It has decreased from 13.51 (Mar 24) to 11.02, marking a decrease of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 10. It has decreased from 6.12 (Mar 24) to 4.48, marking a decrease of 1.64.
- For PBT Margin (%), as of Mar 25, the value is 3.76. This value is below the healthy minimum of 10. It has increased from 2.75 (Mar 24) to 3.76, marking an increase of 1.01.
- For Net Profit Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 5. It has increased from 2.04 (Mar 24) to 2.50, marking an increase of 0.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 8. It has increased from 2.04 (Mar 24) to 2.61, marking an increase of 0.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 15. It has increased from 3.61 (Mar 24) to 3.75, marking an increase of 0.14.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has decreased from 6.92 (Mar 24) to 4.85, marking a decrease of 2.07.
- For Return On Assets (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 5. It has increased from 1.45 (Mar 24) to 2.15, marking an increase of 0.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.00, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 2.15, marking an increase of 0.75.
- For Quick Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 1.90, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 26.84. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 26.84, marking an increase of 26.84.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 81.17. This value exceeds the healthy maximum of 50. It has decreased from 121.71 (Mar 24) to 81.17, marking a decrease of 40.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 23.13. This value is within the healthy range. It has decreased from 26.43 (Mar 24) to 23.13, marking a decrease of 3.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 18.83. This value is below the healthy minimum of 40. It has increased from -21.71 (Mar 24) to 18.83, marking an increase of 40.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 76.87. This value exceeds the healthy maximum of 70. It has increased from 73.57 (Mar 24) to 76.87, marking an increase of 3.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 15.39. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 15.39, marking an increase of 11.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.50. This value is within the healthy range. It has increased from 1.49 (Mar 24) to 4.50, marking an increase of 3.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 947.72. It has decreased from 2,066.51 (Mar 24) to 947.72, marking a decrease of 1,118.79.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 3.72, marking a decrease of 6.00.
- For EV / EBITDA (X), as of Mar 25, the value is 33.70. This value exceeds the healthy maximum of 15. It has decreased from 71.95 (Mar 24) to 33.70, marking a decrease of 38.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For Retention Ratios (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 30. It has increased from -21.71 (Mar 24) to 18.82, marking an increase of 40.53.
- For Price / BV (X), as of Mar 25, the value is 5.75. This value exceeds the healthy maximum of 3. It has decreased from 17.47 (Mar 24) to 5.75, marking a decrease of 11.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vakrangee Ltd:
- Net Profit Margin: 2.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.85% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.75% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 77.8 (Industry average Stock P/E: 82.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Vakrangee Corporate House, Plot No 93, Road No. 16, Mumbai Maharashtra 400093 | info@vakrangee.in http://www.vakrangee.in |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Divya Nandwana | Executive Chairperson |
| Mr. Vedant Nandwana | Managing Director |
| Mr. Hari Chand Mittal | Ind. Non-Executive Director |
| Ms. Savita Keni | Independent Director |
| Mr. L K Shamsunder | Non Exe.Non Ind. & Nominee Director |
| Mr. Sandeep Gaware | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Vakrangee Ltd?
Vakrangee Ltd's intrinsic value (as of 19 January 2026) is ₹4.55 which is 34.81% lower the current market price of ₹6.98, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹754 Cr. market cap, FY2025-2026 high/low of ₹32.4/6.93, reserves of ₹100 Cr, and liabilities of ₹343 Cr.
What is the Market Cap of Vakrangee Ltd?
The Market Cap of Vakrangee Ltd is 754 Cr..
What is the current Stock Price of Vakrangee Ltd as on 19 January 2026?
The current stock price of Vakrangee Ltd as on 19 January 2026 is ₹6.98.
What is the High / Low of Vakrangee Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vakrangee Ltd stocks is ₹32.4/6.93.
What is the Stock P/E of Vakrangee Ltd?
The Stock P/E of Vakrangee Ltd is 77.8.
What is the Book Value of Vakrangee Ltd?
The Book Value of Vakrangee Ltd is 1.93.
What is the Dividend Yield of Vakrangee Ltd?
The Dividend Yield of Vakrangee Ltd is 0.00 %.
What is the ROCE of Vakrangee Ltd?
The ROCE of Vakrangee Ltd is 5.86 %.
What is the ROE of Vakrangee Ltd?
The ROE of Vakrangee Ltd is 3.65 %.
What is the Face Value of Vakrangee Ltd?
The Face Value of Vakrangee Ltd is 1.00.